{"id":"https://openalex.org/W4411287429","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p3-02-17","title":"Abstract P3-02-17: tRF-1432\u2013a novel target for reversing chemoresistance in breast cancer","display_name":"Abstract P3-02-17: tRF-1432\u2013a novel target for reversing chemoresistance in breast cancer","publication_year":2025,"publication_date":"2025-06-13","ids":{"openalex":"https://openalex.org/W4411287429","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p3-02-17"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.sabcs24-p3-02-17","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p3-02-17","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-p3-02-17","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068378986","display_name":"Yuhan Dai","orcid":"https://orcid.org/0000-0002-4472-9608","observed_orcids":["https://orcid.org/0000-0002-4472-9608"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuhan Dai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064389899","display_name":"Shuhan Zhao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuhan Zhao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Huilin Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huilin Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101457873","display_name":"Yue Huang","orcid":"https://orcid.org/0000-0002-8625-7944","observed_orcids":["https://orcid.org/0000-0002-8625-7944"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yue Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102480128","display_name":"Yiqin Xia","orcid":"https://orcid.org/0000-0002-2297-2471","observed_orcids":["https://orcid.org/0000-0002-2297-2471"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yiqin Xia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102382704","display_name":"Jinhui Peng","orcid":"https://orcid.org/0009-0003-9670-4853","observed_orcids":["https://orcid.org/0009-0003-9670-4853"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jinhui Peng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114193896","display_name":"Jiangdong Jin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiangdong Jin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100745759","display_name":"Yifan Wu","orcid":"https://orcid.org/0000-0002-9673-4062","observed_orcids":["https://orcid.org/0000-0002-9673-4062"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yifan Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101400386","display_name":"Shui Wang","orcid":"https://orcid.org/0000-0002-5687-8715","observed_orcids":["https://orcid.org/0000-0002-5687-8715"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shui Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101515271","display_name":"Yangyang Cui","orcid":"https://orcid.org/0009-0009-1107-9301","observed_orcids":["https://orcid.org/0009-0009-1107-9301"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yangyang Cui","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101933598","display_name":"Hui Xie","orcid":"https://orcid.org/0000-0002-6236-4497","observed_orcids":["https://orcid.org/0000-0002-6236-4497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hui Xie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"12_Supplement","first_page":"P3","last_page":"02"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11482","display_name":"RNA modifications and cancer","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11482","display_name":"RNA modifications and cancer","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10521","display_name":"RNA and protein synthesis mechanisms","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trna-derived-fragments","display_name":"tRNA-derived fragments","score":0.984000027179718},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.9380000233650208},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hypoxia","display_name":"hypoxia","score":0.7820000052452087},{"id":"https://openalex.org/keywords/rbms1","display_name":"RBMS1","score":0.953000009059906},{"id":"https://openalex.org/keywords/ccl3","display_name":"CCL3","score":0.9580000042915344},{"id":"https://openalex.org/keywords/ccr5","display_name":"CCR5","score":0.8349999785423279},{"id":"https://openalex.org/keywords/m1-macrophage-polarization","display_name":"M1 macrophage polarization","score":0.921999990940094},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8429999947547913},{"id":"https://openalex.org/keywords/doxorubicin-sensitivity","display_name":"doxorubicin sensitivity","score":0.8299999833106995},{"id":"https://openalex.org/keywords/mrna-stability","display_name":"mRNA stability","score":0.6299999952316284},{"id":"https://openalex.org/keywords/tumor-cell-proliferation","display_name":"tumor cell proliferation","score":0.5019999742507935},{"id":"https://openalex.org/keywords/apoptosis-inhibition","display_name":"apoptosis inhibition","score":0.859000027179718},{"id":"https://openalex.org/keywords/metabolic-reprogramming","display_name":"metabolic reprogramming","score":0.8949999809265137},{"id":"https://openalex.org/keywords/small-rna","display_name":"small RNA","score":0.8100000023841858},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.3869999945163727}],"concepts":[{"id":"https://openalex.org/C2781085045","wikidata":"https://www.wikidata.org/wiki/Q7318308","display_name":"Reversing","level":2,"score":0.8949991464614868},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6914607286453247},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6426419019699097},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.623784065246582},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44706398248672485},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37109947204589844},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26380622386932373},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.sabcs24-p3-02-17","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p3-02-17","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-p3-02-17","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7133503373","https://openalex.org/W4401114830","https://openalex.org/W6939386132","https://openalex.org/W2947093466","https://openalex.org/W4402550161","https://openalex.org/W2898200756","https://openalex.org/W4255920600","https://openalex.org/W3203873383","https://openalex.org/W2519631966","https://openalex.org/W6958721348"],"abstract_inverted_index":{"Abstract":[0],"Chemoresistance":[1],"is":[2,12,48,152],"a":[3,34,106,205,210,223,227,316],"significant":[4,206],"challenge":[5],"in":[6,19,71,93,99,133,169,172,197,217,236,256,300,322,355],"the":[7,13,40,44,66,138,177,189,215,218,237,251,262,267,281,295,308,362],"field":[8],"of":[9,16,69,109,144,150,166,185,194,208,220,230,239,264,269,297,311,361],"oncology":[10],"and":[11,61,128,141,159,162,171,182,191,249,279,283,304,306],"leading":[14],"cause":[15],"treatment":[17,62],"failure":[18],"breast":[20,72,94,101,167,200,257,285,301,323,356],"cancer.":[21,73,258,324],"Cancer":[22,366,379],"cells":[23,202],"could":[24,213,244],"adapt":[25],"to":[26,54,57,64,253,314],"hypoxia":[27,96],"microenvironment":[28,232],"through":[29,90],"metabolic":[30],"reprogramming,":[31],"while":[32,87],"developing":[33],"strong":[35],"drug":[36],"resistance":[37],"phenotype":[38,219],"at":[39],"same":[41],"time.":[42],"However,":[43],"mechanism":[45,310],"under":[46,125],"which":[47,129,212],"still":[49],"largely":[50],"unknown.":[51],"Efforts":[52],"need":[53],"be":[55],"done":[56],"identify":[58],"novel":[59,317,350],"targets":[60],"modalities":[63],"address":[65],"complex":[67],"issue":[68],"chemoresistance":[70,165,192,284,321,354],"In":[74,290],"this":[75],"study,":[76],"we":[77,88,203],"set":[78],"our":[79,292],"sights":[80],"on":[81,137],"an":[82],"upregulated":[83],"tRNA-derived":[84],"fragment,":[85],"tRF-1432,":[86],"screened":[89],"high-throughput":[91],"sequencing":[92],"cancer":[95,102,168,201,286,302,357],"models,":[97],"especially":[98],"drug-resistant":[100],"cells/tissues.":[103],"tRFs":[104],"are":[105,120],"new":[107],"category":[108],"small":[110],"non-coding":[111],"RNAs":[112],"that":[113],"occur":[114],"when":[115],"pre-tRNAs":[116],"or":[117],"mature":[118],"tRNAs":[119],"selectively":[121],"sheared":[122],"by":[123],"enzymes":[124],"certain":[126],"pressure,":[127],"play":[130],"crucial":[131,228],"roles":[132,140],"tumorigenesis.":[134],"Further":[135],"investigation":[136],"biological":[139],"clinical":[142],"value":[143],"tRF-1432":[145,151,181,198,243,260,299],"has":[146],"been":[147],"done.":[148],"Overexpression":[149],"positively":[153],"correlated":[154],"with":[155,266],"tumor":[156,231],"cell":[157],"proliferation":[158],"anti-apoptosis":[160],"ability,":[161],"significantly":[163],"increased":[164],"vitro":[170],"vivo.":[173],"Immunoprecipitation":[174],"experiments":[175],"confirmed":[176],"direct":[178],"bond":[179],"between":[180],"RBMS1,":[183,273],"knockdown":[184],"RBMS1":[186],"may":[187],"deprive":[188],"tumor-promoting":[190],"properties":[193],"tRF-1432.":[195],"Furthermore,":[196],"overexpression":[199],"observed":[204],"decrease":[207],"CCL3,":[209],"gene":[211],"induce":[214],"transition":[216],"macrophages":[221,234],"into":[222],"proinflammatory":[224],"one.":[225],"As":[226],"member":[229],"(TME),":[233],"participate":[235],"mediation":[238],"therapeutic":[240],"responses.":[241],"Silencing":[242],"facilitate":[245],"M1":[246,276],"macrophage":[247,277],"polarization":[248,278],"enhance":[250],"response":[252],"doxorubicin":[254],"chemosensitivity":[255],"Mechanismly,":[259],"decreased":[261],"stability":[263],"CCL3-mRNA":[265],"cooperation":[268],"RNA":[270],"binding":[271],"protein":[272],"thereby":[274],"reduced":[275],"promote":[280],"progression":[282],"via":[287],"CCL3-CCR5":[288],"signaling.":[289],"conclusion,":[291],"study":[293],"clarified":[294],"role":[296],"hypoxia-induced":[298],"development":[303],"chemoresistance,":[305],"elucidate":[307],"molecular":[309],"which,":[312],"aiming":[313],"provide":[315],"target":[318,351],"for":[319,352],"reversing":[320,353],"Citation":[325],"Format:":[326],"Yuhan":[327],"Dai,":[328],"Shuhan":[329],"Zhao,":[330],"Huilin":[331],"Chen,":[332],"Yue":[333],"Huang,":[334],"Yiqin":[335],"Xia,":[336],"Jinhui":[337],"Peng,":[338],"Jiangdong":[339],"Jin,":[340],"Yifan":[341],"Wu,":[342],"Shui":[343],"Wang,":[344],"Yangyang":[345],"Cui,":[346],"Hui":[347],"Xie.":[348],"tRF-1432\u2013a":[349],"[abstract].":[358],"In:":[359],"Proceedings":[360],"San":[363,372],"Antonio":[364],"Breast":[365],"Symposium":[367],"2024;":[368],"2024":[369],"Dec":[370],"10-13;":[371],"Antonio,":[373],"TX.":[374],"Philadelphia":[375],"(PA):":[376],"AACR;":[377],"Clin":[378],"Res":[380],"2025;31(12":[381],"Suppl):Abstract":[382],"nr":[383],"P3-02-17.":[384]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2025-10-10T00:00:00"}